After participating in this educational activity, attendees should be able to:
1. Describe presentations of a child with primary immunodeficiency disease
2. Discuss the approach to the work up of primary immunodeficiency disease and differential diagnosis
3. Review the approach to work up of a variant of unknown significance on genetic sequencing
4. Describe presentation of deep soft tissue infections
5. Identify types and etiologies of deep soft tissue infection
6. Review management strategies for deep soft tissue infections


Donna Fisher, MD
Associate Professor of Pediatrics
UMMS - Baystate

Alicia Johnston, MD
Assistant Professor of Pediatrics
UMMS - Baystate



Faculty Disclosure
Shannon Kay, PH.D., BCBA-D is a stock shareholder in Allergan, Pfizer, Glaxosmithklein, Merck, Gilead.

Session date: 
07/16/2019 - 8:00am to 9:00am EDT
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.